Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its salts

The present disclosure relates to a method of treating or preventing a disease or disorder selected from the group consisting of a central nervous system disorder, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, a chronic granulomatous disorder, a polycystic ovary syndrome, a thyroid...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	MARTINELL PEDEMONTE Marc, TRAVER LOPEZ Estefania, GARCIA COLLAZO Ana Maria, PEREZ DE LA CRUZ MORENO Maria Angeles, PIZCUETA LALANZA Maria Pilar
Format:	Patent
Sprache:	eng ; heb
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!